A medical board is evaluating a recently developed serum biomarker assay used to screen for early-stage pancreatic cancer. The biomarker is a continuous variable, and higher serum concentrations are associated with a greater likelihood of malignancy. The original diagnostic cutoff for a positive test was established to prioritize early detection in the general population. Following a one-year review, it is found that an unacceptable number of healthy patients are undergoing highly invasive confirmatory pancreatic biopsies due to false-positive assay results. To minimize the incidence of these unnecessary and risky procedures, the board decides to adjust the diagnostic cutoff value. Assuming the prevalence of pancreatic cancer in the screened population remains constant, which of the following pairs of changes in test characteristics will most likely occur as a direct result of this adjustment?
- Increase in the false-negative rate and increase in the positive predictive valueAnswer
- BDecrease in the false-negative rate and increase in the negative predictive value
- CIncrease in sensitivity and decrease in the positive predictive value
- DDecrease in specificity and decrease in the negative predictive value
- EDecrease in the positive predictive value and increase in the negative predictive value